For citations & permissions, please see: Citations & Permissions - Wiley Science Solutions*

*Links on SpectraBase are not permalinks.

(+)-(1R,2R,3S)-2-(1-n-Butyl-2-isobutylcarbonyloxy-3-methoxymethoxybutyl)-4,5-diphenyloxazole

Compound with spectra: 1 MS (GC)

(+)-(1R,2R,3S)-2-(1-n-Butyl-2-isobutylcarbonyloxy-3-methoxymethoxybutyl)-4,5-diphenyloxazole
SpectraBase Compound ID ANract6eVBm
InChI InChI=1S/C30H39NO5/c1-6-7-18-25(28(22(4)34-20-33-5)35-26(32)19-21(2)3)30-31-27(23-14-10-8-11-15-23)29(36-30)24-16-12-9-13-17-24/h8-17,21-22,25,28H,6-7,18-20H2,1-5H3/t22-,25+,28-/m0/s1
InChIKey OOQUBDUTCVCNGA-DLNIMUOOSA-N
Mol Weight 493.6 g/mol
Molecular Formula C30H39NO5
Exact Mass 493.282823 g/mol
Enantiomer InChIKey OOQUBDUTCVCNGA-MDQGVCTMSA-N

View Spectrum of (+)-(1R,2R,3S)-2-(1-n-Butyl-2-isobutylcarbonyloxy-3-methoxymethoxybutyl)-4,5-diphenyloxazole

MS (GC) Spectrum
Copyright Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved.
Source of Spectrum F-48-7066-13
4-(5-Bromo-2-phenoxyphenyl)-2,5-diphenyloxazole
Diltiazem-M -H2O AC
(2S,5S,1'S)-2-(tert-Butyl)-5-(3'-oxo-1'-phenylbutyl)-5-phenyl-1,3-dioxolan-4-one
(2R,5S,1'R)-2-(tert-Butyl)-5-(3'-oxo-1'-phenylbutyl)-5-phenyl-1,3-dioxolan-4-one
Zolpidem - metabolite III derivatized with diazomethane - first isomer acetylated
9-BETA-(3-HYDROXY-3-METHYLPENTANOYLOXY)-PARTHENOLIDE
3-[2-(dipropylamino)-2-keto-ethyl]-2-phenyl-imidazo[1,2-a]pyridine-6-carboxylic acid methyl ester
2,3-Dideoxy-5,6,7,9-tetra-O-benzyl-2-methylidene-.alpha.-D-manno-4,8-pyranoso-non-4-ulonitrile
methyl 4-(4-chlorophenyl)-2-[(9H-xanthen-9-ylcarbonyl)amino]-3-thiophenecarboxylate
N-[4-[1-(3-Iodo-benzyl)-1H-benzoimidazol-2-yl]-furazan-3-yl]acetamide
Other Resources
Unknown Identification

Search your unknown spectrum against the world's largest collection of reference spectra

KnowItAll Campus Solutions

KnowItAll offers faculty and students at your school access to all the tools you need for spectral analysis and structure drawing & publishing! Plus, access the world's largest spectral library.